Immunotherapy Treats Recurrent Laryngeal Cancer: A Physician and Patient Perspective

Head and neck cancer surgeon Christine Gourin and patient Jerry, who had a recurrence of laryngeal cancer, discuss his long-term response to immunotherapy as part of a clinical trial in which he participated in 2014, a time when research into immunotherapy as a potential cancer treatment was in its early days.

Share Fast Facts

In 2014, a @HopkinsKimmel patient participated in a clinical trial for immunotherapy as a potential treatment for head and neck cancer. Learn about the outcomes below. Click to Tweet


Created by

Johns Hopkins Medicine

Related Presenters

Christine Gourin, MD, MPH

Christine Gourin, MD, MPH

Professor of Otolaryngology - Head and Neck Surgery

EXPERTISE Basal Cell Cancer of the Head and Neck, Carcinoma of the Tongue, Head and Neck Cancers, Head and Neck Surgery, Head and Neck Tumors, HPV- Related Head and Neck Cancer, Hypopharyngeal Cancer, Laryngeal Cancer, Melanoma, Melanoma ...

View full profile